ebselen has been researched along with Blood Clot in 1 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
Excerpt | Relevance | Reference |
---|---|---|
"In ebselen-pretreated animals (30 mg/kg ip), venular thrombus formation was significantly delayed (50% vessel occlusion: 535+/-34 s; initial stasis: 872+/-82 s; complete occlusion: 908+/-87 s) as compared to vehicle-treated controls (416+/-42; 612+/-49; 647+/-51)." | 1.32 | Anti-oxidant ebselen delays microvascular thrombus formation in the rat cremaster muscle by inhibiting platelet P-selectin expression. ( Belusa, L; Lindenblatt, N; Menger, MD; Nickels, RM; Schareck, W; Vollmar, B, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lindenblatt, N | 1 |
Schareck, W | 1 |
Belusa, L | 1 |
Nickels, RM | 1 |
Menger, MD | 1 |
Vollmar, B | 1 |
1 other study available for ebselen and Blood Clot
Article | Year |
---|---|
Anti-oxidant ebselen delays microvascular thrombus formation in the rat cremaster muscle by inhibiting platelet P-selectin expression.
Topics: Animals; Antioxidants; Azoles; Blood Platelets; Dose-Response Relationship, Drug; Hydrogen Peroxide; | 2003 |